{
  "retracted": false,
  "timestamp": 1475280000000,
  "updates": [
    {
      "timestamp": 1557249110158,
      "identifier": {
        "doi": "10.1016/j.atherosclerosis.2016.05.012"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.atherosclerosis.2016.01.036"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease” [Atherosclerosis 247 (2016) 48–57]"
}
